This is a renewal of the existing Emory University Vaccinology Training Program T32 that was first funded in 2009. Emory is uniquely positioned to train a cadre of scientists with expertise in multi-disciplinary approaches to vaccines. The faculty preceptors have the breadth of expertise and mentoring experience that are critical for training a new generation of Vaccinologists. The preceptors are affiliated with several departments and programs at Emory, including the Emory Schools of Medicine and School of Public Health, the Emory Vaccine Center and the joint Emory-Georgia Institute of Technology (GA Tech) Biomedical Engineering Department at Emory. The preceptors have extensive training experience across several Vaccinology disciplines, including microbiology and immunology, infectious diseases, public health, pathology, pediatrics, epidemiology, behavior, global health, and health policy. This renewal application proposes support for five postdoctoral fellows (MD, PhD, or MD/PhD)-an increase of one fellow-to engage in full-time Vaccinology training. The fellows receive formal and informal education and career mentoring, and conduct mentored research. Our trainees acquire the skills and background necessary for their success as Vaccinology leaders in the future. Each trainee selects an in depth mentored research project with a preceptor from one of four Research Training Sections: 1) Pathogenesis &Vaccine Discovery;2) Innate &Adaptive Immune Responses to Bacterial, Protozoal, &Viral Antigens;3) Vaccine Epidemiology &Health Policy;and 4) Translation, Delivery &Clinical Trials. Every trainee participates in two required comprehensive graduate level courses emphasizing different aspects of the field of Vaccinology, and a third required course in Research Ethics. The specific goals of the Program include: " To Inspire and attract outstanding post-doctoral trainees to pursue interdisciplinary training in preparation for independent vaccinology research careers; " To integrate the strong basic science, translational research, and clinical trials programs at Emory into a multi-faceted training experience, producing a synergistic whole greater than the sum of its individual parts; " To train MD and PhD scientists committed to careers in vaccine research to incorporate innovative basic science tools into Vaccinology and public health; " To provide each trainee with formal and informal Vaccinology education, a mentoring team for his or her collaborative multidisciplinary research project, and career mentoring.

Public Health Relevance

This application responds to an urgent need to train a new generation of Vaccinologists. Vaccines have dramatically reduced the spread of infectious diseases, show great potential for preventing and controlling chronic conditions, and highly cost-effective. However, to achieve the full potential of vaccines and address difficulties that have hindered progress, a new generation of well-prepared scientists is needed.

National Institute of Health (NIH)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Microbiology and Infectious Diseases Research Committee (MID)
Program Officer
Robbins, Christiane M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Emory University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Burke, Rachel M; Smith, Emily R; Dahl, Rebecca Moritz et al. (2014) The economic burden of pediatric gastroenteritis to Bolivian families: a cross-sectional study of correlates of catastrophic cost and overall cost burden. BMC Public Health 14:642
Boyoglu-Barnum, Seyhan; Chirkova, Tatiana; Todd, Sean O et al. (2014) Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice. J Virol 88:10569-83
Ellebedy, Ali H; Krammer, Florian; Li, Gui-Mei et al. (2014) Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proc Natl Acad Sci U S A 111:13133-8
Rivera, Rosario; Forney, Kristen; Castro, Maria Rene et al. (2013) Rotavirus genotype distribution during the pre-vaccine period in Bolivia: 2007-2008. Int J Infect Dis 17:e762-7
Burke, Rachel M; Rebolledo, Paulina A; Embrey, Sally R et al. (2013) The burden of pediatric diarrhea: a cross-sectional study of incurred costs and perceptions of cost among Bolivian families. BMC Public Health 13:708
Wingood, Gina M; Dunkle, Kristin; Camp, Christina et al. (2013) Racial differences and correlates of potential adoption of preexposure prophylaxis: results of a national survey. J Acquir Immune Defic Syndr 63 Suppl 1:S95-101
Hale, J Scott; Youngblood, Ben; Latner, Donald R et al. (2013) Distinct memory CD4+ T cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection. Immunity 38:805-17
Boyoglu-Barnum, Seyhan; Gaston, Kelsey A; Todd, Sean O et al. (2013) A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice. J Virol 87:10955-67
Herbert, Natasha L; Gargano, Lisa M; Painter, Julia E et al. (2013) Understanding reasons for participating in a school-based influenza vaccination program and decision-making dynamics among adolescents and parents. Health Educ Res 28:663-72
Le, Vy L; Courtney, Cynthia L; Steel, John et al. (2013) Closely related influenza viruses induce contrasting respiratory tract immunopathology. PLoS One 8:e76708

Showing the most recent 10 out of 23 publications